Vancouver's Zymeworks spurns 'opportunistic' $1B acquisition offer - Business News - Castanet.net

5/20/2022 12:00:00 AM2 years 11 months ago

Billion-dollar bid ‘inadequate,’ says biotech CEO

The board of embattled B.C. biotech Zymeworks Inc. (NYSE:ZYME) has rebuffed a billion-dollar bid to buy the company. Late last month Dubai-based All Blue Falcons FZE (ABF) made an solicited proposal… [+2161 chars]

full article...